Bloomberg Opinion seeks a pharma columnist
The energy of a newsroom. The pace of a trading floor. We work hard, and we work fast — while keeping up the creativity and entrepreneurialism we’re known for. It’s what keeps us inventing and reinventing, all the time.
Bloomberg LP has built a significant media business spanning television, digital, magazine, radio and live event platforms across the globe. In the midst of a historic time in the media industry, Bloomberg Media is growing its global footprint and reach through new innovations from Quicktake to New Economy to our rapidly growing consumer subscription business.
The Bloomberg Opinion pharma writer will produce commentary and analysis about drug and biotech companies, identifying the most important themes and ideas at the intersection of science and business. This will entail looking at products, corporate strategies and political interests — as well as the regulatory agencies that monitor them, and their influence on people’s lives.
The person will also cover bioscience generally, drug innovation and issues in public health. Knowledge of markets, investing and the financial world will be important to this beat.
To apply, go here.